Oral Anti-Cancer Therapy: Meeting the Challenges of this New Practice Paradigm

2.50
Hdl Handle:
http://hdl.handle.net/10755/153938
Type:
Presentation
Title:
Oral Anti-Cancer Therapy: Meeting the Challenges of this New Practice Paradigm
Abstract:
Oral Anti-Cancer Therapy: Meeting the Challenges of this New Practice Paradigm
Conference Sponsor:Sigma Theta Tau International
Conference Year:2009
Author:Roop, Janna C., PhD, RN, CHPN
P.I. Institution Name:Wayne State University
Title:Assistant Professor (Clinical)
[Research Presentation] Purpose: The study has two aims regarding oral oncolytic drugs: 1) to explore the experiences of patients who receive outpatient administration of anti-cancer drugs by mouth and 2) to query nurses about current practices and their experiences of caring for patients who take anti-cancer drugs by mouth. The specific aims are the following:1. To uncover patients' perceptions and experiences related to following prescribed oral anti-cancer therapies; 2. To identify common barriers to adherence to the regimen; 3. To determine if there are specific times when adherence is most difficult (one week after starting therapy, two weeks, two months, etc.); 4. To uncover nurses' perspectives relative to treatment adherence; 5. To identify current practices regarding patients who are taking anti-cancer drugs by mouth; and 6. To identify illness-related, treatment-related, and symptom characteristics of the patients who receive oral anti-cancer therapies. Methods: The investigators will interview patients about their experiences taking anti-cancer drugs by mouth. The interviews will be transcribed to create a text, which will be analyzed for content, themes, and differences. When no new information is emerging from the interviews, the investigators will recruit additional patients until a total sample size of 40 is achieved. These additional patients will not be interviewed, but will complete the 4 questionnaires. All patients (interview and instrument-only) will be asked to complete 4 questionnaires to describe their general symptoms, fatigue, sleep problems, and quality of life. The investigators will examine all 40 patients' medical records to obtain demographic, disease-related, and treatment-related information. The investigators will also conduct focus groups for clinical nurses, which will be transcribed and examined for commonalities, themes, and differences. Nurses will also complete 1 short questionnaire about their patients' symptoms. Results: Data collection is just beginning (November, 2008). Preliminary results will be reported at the Research Congress. Conclusion: As above, data collection & analysis is just beginning.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleOral Anti-Cancer Therapy: Meeting the Challenges of this New Practice Paradigmen_GB
dc.identifier.urihttp://hdl.handle.net/10755/153938-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Oral Anti-Cancer Therapy: Meeting the Challenges of this New Practice Paradigm</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2009</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Roop, Janna C., PhD, RN, CHPN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Wayne State University</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor (Clinical)</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">roop@wayne.edu</td></tr><tr><td colspan="2" class="item-abstract">[Research Presentation] Purpose: The study has two aims regarding oral oncolytic drugs: 1) to explore the experiences of patients who receive outpatient administration of anti-cancer drugs by mouth and 2) to query nurses about current practices and their experiences of caring for patients who take anti-cancer drugs by mouth. The specific aims are the following:1. To uncover patients' perceptions and experiences related to following prescribed oral anti-cancer therapies; 2. To identify common barriers to adherence to the regimen; 3. To determine if there are specific times when adherence is most difficult (one week after starting therapy, two weeks, two months, etc.); 4. To uncover nurses' perspectives relative to treatment adherence; 5. To identify current practices regarding patients who are taking anti-cancer drugs by mouth; and 6. To identify illness-related, treatment-related, and symptom characteristics of the patients who receive oral anti-cancer therapies. Methods: The investigators will interview patients about their experiences taking anti-cancer drugs by mouth. The interviews will be transcribed to create a text, which will be analyzed for content, themes, and differences. When no new information is emerging from the interviews, the investigators will recruit additional patients until a total sample size of 40 is achieved. These additional patients will not be interviewed, but will complete the 4 questionnaires. All patients (interview and instrument-only) will be asked to complete 4 questionnaires to describe their general symptoms, fatigue, sleep problems, and quality of life. The investigators will examine all 40 patients' medical records to obtain demographic, disease-related, and treatment-related information. The investigators will also conduct focus groups for clinical nurses, which will be transcribed and examined for commonalities, themes, and differences. Nurses will also complete 1 short questionnaire about their patients' symptoms. Results: Data collection is just beginning (November, 2008). Preliminary results will be reported at the Research Congress. Conclusion: As above, data collection &amp; analysis is just beginning.</td></tr></table>en_GB
dc.date.available2011-10-26T12:37:30Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T12:37:30Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.